ConductScience.org, home

Paper423973

Dopamine inhibits adenylate cyclase in human prolactin-secreting pituitary adenomas.

De Camilli P and 2 others. Nature, 1979. Cited by 269 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Dopamine inhibits adenylate cyclase in human prolactin-secreting pituitary adenomas. Papers, record 423973. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/423973

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Dopamine inhibits adenylate cyclase in human prolactin-secreting pituitary adenomas.
PubMed
Journal
Nature
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
269
iCite
Relative citation ratio, by iCite
8.44
iCite
Revised in PubMed
2019-06-17
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1De Camilli PP
2Macconi DD
3Spada AA

Source PubMed

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AdenomaMajor topic
Adenylyl Cyclase InhibitorsMajor topic
DopamineMajor topic
Pituitary NeoplasmsMajor topic
ProlactinMajor topic
Bromocriptine
Fluphenazine
Humans
Norepinephrine
Receptors, Dopamine

Source PubMed

Cited by43

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 269 citations.

PMIDTitleJournalYearIn PapersSource
41,348,744Neuromodulatory control of energy reserves in dopaminergic neurons.Proc Natl Acad Sci U S A2025https://conductscience.org/library/papers/41348744PubMed
37,047,716Unveiling the Differences in Signaling and Regulatory Mechanisms between Dopamine D2 and D3 Receptors and Their Impact on Behavioral Sensitization.Int J Mol Sci2023https://conductscience.org/library/papers/37047716PubMed
34,385,603How changes in dopamine D2 receptor levels alter striatal circuit function and motivation.Mol Psychiatry2022https://conductscience.org/library/papers/34385603PubMed
33,919,025Roles of the Functional Interaction between Brain Cholinergic and Dopaminergic Systems in the Pathogenesis and Treatment of Schizophrenia and Parkinson's Disease.Int J Mol Sci2021https://conductscience.org/library/papers/33919025PubMed
33,706,940Effects of nicotine on DARPP-32 and CaMKII signaling relevant to addiction.Adv Pharmacol2021https://conductscience.org/library/papers/33706940PubMed
33,535,394Somatostatin-Dopamine Chimeric Molecules in Neuroendocrine Neoplasms.J Clin Med2021https://conductscience.org/library/papers/33535394PubMed
32,659,920Dopamine D3 Receptor Heteromerization: Implications for Neuroplasticity and Neuroprotection.Biomolecules2020https://conductscience.org/library/papers/32659920PubMed
27,900,635Somatostatin and dopamine receptor regulation of pituitary somatotroph adenomas.Pituitary2017https://conductscience.org/library/papers/27900635PubMed
25,254,141Pharmacological overview of galactogogues.Vet Med Int2014https://conductscience.org/library/papers/25254141PubMed
24,957,966Light responsive polymer membranes: a review.Membranes (Basel)2012https://conductscience.org/library/papers/24957966PubMed
23,129,328Dopamine receptor signaling and current and future antipsychotic drugs.Handb Exp Pharmacol2012https://conductscience.org/library/papers/23129328PubMed
23,087,877Spontaneous reduction of prolactinoma post cabergoline withdrawal.Indian J Endocrinol Metab2012https://conductscience.org/library/papers/23087877PubMed
21,653,876Estrogen regulation of the dopamine-activated GIRK channel in pituitary lactotrophs: implications for regulation of prolactin release during the estrous cycle.Am J Physiol Regul Integr Comp Physiol2011https://conductscience.org/library/papers/21653876PubMed
19,909,227Third generation antipsychotic drugs: partial agonism or receptor functional selectivity?Curr Pharm Des2010https://conductscience.org/library/papers/19909227PubMed
17,638,086Pituitary development and physiology.Pituitary2007https://conductscience.org/library/papers/17638086PubMed
17,570,067Pituitary apoplexy during treatment of cystic macroprolactinomas with cabergoline.Pituitary2008https://conductscience.org/library/papers/17570067PubMed
16,411,068Pharmacologic resistance in prolactinoma patients.Pituitary2005https://conductscience.org/library/papers/16411068PubMed
15,159,529Biography of Pietro De Camilli.Proc Natl Acad Sci U S A2004https://conductscience.org/library/papers/15159529PubMed
14,674,720Dopamine resistance of prolactinomas.Pituitary2003https://conductscience.org/library/papers/14674720PubMed
11,081,193Growth factors in pituitary tumors.Pituitary1999https://conductscience.org/library/papers/11081193PubMed

See all 43 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/423973

GET https://conductscience.org/api/papers/v1/423973/cited_by?page=2